SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants Orphan Drug Designation to Bayer HealthCare AG's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors